1. Home
  2. ACIU vs CDZI Comparison

ACIU vs CDZI Comparison

Compare ACIU & CDZI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACIU
  • CDZI
  • Stock Information
  • Founded
  • ACIU 2003
  • CDZI 1983
  • Country
  • ACIU Switzerland
  • CDZI United States
  • Employees
  • ACIU N/A
  • CDZI N/A
  • Industry
  • ACIU Biotechnology: Pharmaceutical Preparations
  • CDZI Water Supply
  • Sector
  • ACIU Health Care
  • CDZI Utilities
  • Exchange
  • ACIU Nasdaq
  • CDZI Nasdaq
  • Market Cap
  • ACIU 247.4M
  • CDZI 247.1M
  • IPO Year
  • ACIU 2016
  • CDZI N/A
  • Fundamental
  • Price
  • ACIU $1.88
  • CDZI $2.96
  • Analyst Decision
  • ACIU Strong Buy
  • CDZI
  • Analyst Count
  • ACIU 2
  • CDZI 0
  • Target Price
  • ACIU $12.00
  • CDZI N/A
  • AVG Volume (30 Days)
  • ACIU 187.3K
  • CDZI 654.8K
  • Earning Date
  • ACIU 03-13-2025
  • CDZI 05-13-2025
  • Dividend Yield
  • ACIU N/A
  • CDZI N/A
  • EPS Growth
  • ACIU N/A
  • CDZI N/A
  • EPS
  • ACIU N/A
  • CDZI N/A
  • Revenue
  • ACIU $30,136,397.00
  • CDZI $9,608,000.00
  • Revenue This Year
  • ACIU $120.91
  • CDZI $80.27
  • Revenue Next Year
  • ACIU $13.82
  • CDZI $0.69
  • P/E Ratio
  • ACIU N/A
  • CDZI N/A
  • Revenue Growth
  • ACIU 84.51
  • CDZI 382.57
  • 52 Week Low
  • ACIU $1.77
  • CDZI $2.12
  • 52 Week High
  • ACIU $4.98
  • CDZI $5.68
  • Technical
  • Relative Strength Index (RSI)
  • ACIU 29.21
  • CDZI 25.14
  • Support Level
  • ACIU $1.77
  • CDZI $2.85
  • Resistance Level
  • ACIU $2.05
  • CDZI $3.53
  • Average True Range (ATR)
  • ACIU 0.12
  • CDZI 0.14
  • MACD
  • ACIU -0.02
  • CDZI -0.01
  • Stochastic Oscillator
  • ACIU 18.71
  • CDZI 14.00

About ACIU AC Immune SA

AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The Company has one segment. The Company currently focuses most of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.

About CDZI CADIZ Inc.

Cadiz Inc is a land and water resource development company in California. Its primary business is to acquire and develop land with water resources for various uses, including groundwater supply, groundwater storage, and agriculture. The company focuses on the development of the Cadiz Valley Water Conservation, Recovery and Storage Project which will capture and conserve native groundwater currently being lost to evaporation from the aquifer system beneath the property of Cadiz and Fenner valleys of eastern San Bernardino County, and deliver it to water providers throughout Southern California. The company operates in two segment- Land and Water Resources and ATEC Water Systems LLC.

Share on Social Networks: